{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:28:29Z","timestamp":1788406109012,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.rbmo.2020.11.012","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T20:19:27Z","timestamp":1606335567000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids"],"prefix":"10.1016","volume":"42","author":[{"given":"Lisa","family":"Calderon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-0800","authenticated-orcid":false,"given":"Antoine","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Grob-Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Siles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubert","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2020.11.012_bib0001","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/humrep\/16.11.2427","article-title":"Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology","volume":"16","author":"Bazot","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2018.01.024","article-title":"Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis","volume":"109","author":"Bazot","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1148\/radiology.179.2.1707545","article-title":"Uterine junctional zone: correlation between histologic findings and MR imaging","volume":"179","author":"Brown","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.09.038","article-title":"Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study","volume":"101","author":"Brucker","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0006","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3109\/00016349.2010.512061","article-title":"Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy","volume":"89","author":"Champaneria","year":"2010","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmz049","article-title":"Diagnosing adenomyosis: an integrated clinical and imaging approach","author":"Chapron","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000009939","article-title":"Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen","volume":"45","author":"Cohen","year":"1998","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09513590.2018.1505846","article-title":"Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids","volume":"35","author":"Conway","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/14740338.2018.1550070","article-title":"Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program","volume":"17","author":"Donnez","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0013","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate\u2729","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2020.04.017","article-title":"Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis","author":"Donnez","year":"2020","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0016","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0015-0282(01)01962-8","article-title":"Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis","volume":"76","author":"Dueholm","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0017","article-title":"Esmya: new measures to minimise risk of rare but serious liver injury [WWW Document","year":"2018","journal-title":"European Medicines Agency"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0018","doi-asserted-by":"crossref","first-page":"177","DOI":"10.23736\/S0026-4784.18.04291-0","article-title":"Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance","volume":"71","author":"Filip","year":"2019","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2017.12.030","article-title":"Pathogenesis of uterine adenomyosis: invagination or metaplasia?","volume":"109","author":"Garc\u00eda-Solares","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0020","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jmig.2018.04.002","article-title":"Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas","volume":"25","author":"Gracia","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.06.027","article-title":"Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification","volume":"207","author":"Kishi","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0022","first-page":"3292","article-title":"Progesterone induction of 17beta-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogen-dependent benign diseases but not in normal endometrium","volume":"85","author":"Kitawaki","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2559.2000.01001.x","article-title":"Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias","volume":"37","author":"McCluggage","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0024","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.rbmo.2019.07.028","article-title":"Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study","volume":"39","author":"Netter","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1933719110377118","article-title":"Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent","volume":"17","author":"Nie","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0026","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/molehr\/gah113","article-title":"Functional characterization of somatic point mutations of the human estrogen receptor alpha (hERalpha) in adenomyosis uteri","volume":"10","author":"Oehler","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiology.199.1.8633139","article-title":"Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation","volume":"199","author":"Reinhold","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1148\/radiology.179.2.2014282","article-title":"Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens","volume":"179","author":"Scoutt","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0029","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.rbmo.2017.06.016","article-title":"Pathogenesis of adenomyosis: an update on molecular mechanisms","volume":"35","author":"Vannuccini","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2020.11.012_bib0030","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.11.012_bib0031","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int. J. Gynecol. Pathol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320306283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320306283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:21:17Z","timestamp":1761466877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320306283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1472648320306283"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.11.012","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}